🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robin L. Jones

Royal Marsden Hospital

ORCID: 0000-0003-4173-3844
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial

(2023)10.1158/1078-0432.c.6530537
Top 100%
0DataRank
Top 100%0 citations

Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine +5 more

Papers

Driven by 13 papers — median percentile 0. Top paper: “Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study”.

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Nature Cancer(2021)10.1038/s43018-021-00274-w
N/A
6.8DataRank · unranked
185 citations

Scott T.C. Shepherd, Lewis Au, Katalin A. Wilkinson, Mary Wu, Fiona Byrne +91 more

Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4592
N/A
2.3DataRank · unranked
46 citations

Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine +5 more

Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4239
N/A
1.4DataRank · unranked
46 citations

Laura Riolobos, Bonnie LaFleur, Matthew B. Spraker, Yongwoo David Seo, Kimberly S. Smythe +24 more

Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib

Annals of Oncology(2023)10.1016/j.annonc.2023.04.006
N/A
1.2DataRank · unranked
42 citations

Sebastian Bauer, David Gómez-Peregrina, Yoon‐Koo Kang, Robin L. Jones, Piotr Rutkowski +13 more

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2232
N/A
0.749DataRank · unranked
146 citations

Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more

A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0240
N/A
0.529DataRank · unranked
33 citations

Yuzheng Zhang, Lee D. Cranmer, Elizabeth T. Loggers, Graeme Black, Sabrina McDonnell +10 more

A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis

The Lancet Oncology(2023)10.1016/s1470-2045(23)00462-x
N/A
0DataRank · unranked
61 citations

Matthew Orton, Robby Emsley, Sharon Vit, Christian Kelly‐Morland, D. Strauß +21 more

Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients

Cancers(2022)10.3390/cancers14051290
N/A
0DataRank · unranked
11 citations

Yuzheng Zhang, Kimberly S. Smythe, Parth Desai, Anish Thomas, Pedro Viveiros +11 more

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma

Cancers(2023)10.3390/cancers15092617
N/A
0DataRank · unranked
17 citations

Hilary Dietz, Sheima Farag, Angela C. Hirbe, Michael J. Wagner, Brian A. Van Tine +5 more

Data from Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial

(2023)10.1158/1078-0432.c.6530537
Top 100%
0DataRank
Top 100%0 citations

Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine +5 more

Data from Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells

(2023)10.1158/1078-0432.c.6532685.v1
Top 100%
0DataRank
Top 100%0 citations

Laura Riolobos, Bonnie LaFleur, Matthew B. Spraker, Yongwoo David Seo, Kimberly S. Smythe +24 more

Novel trial designs for patients with gastrointestinal stromal tumor

ESMO Open(2024)10.1016/j.esmoop.2023.102218
N/A
0DataRank · unranked
3 citations

S. Rothschild, Guillermo Villacampa, Michael C. Heinrich, Sally L. George, Jean‐Yves Blay +10 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618
N/A
0DataRank · unranked
229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more